2021 | HFSA

Heart Failure Society of America, Heart Failure Association of European Society of Cardiology, and Japanese Heart Failure Society Release Position Statement on Endomyocardial Biopsy

HFSA News Heart Failure Guidelines

ROCKVILLE, MARYLAND (May 19, 2021) - The Heart Failure Society of America (HFSA), the Heart Failure Association of the European Society of Cardiology (HFA-ESC) and the Japanese Heart Failure Society (JHFS) released a new HFA/HFSA/JHFS Position Statement on Endomyocardial Biopsy today. The position statement “represents an expert consensus aiming to provide a comprehensive, up-to-date perspective on EMB, with a focus on the following main issues: 1) an overview of the practical approach to EMB, 2) an update on indications for EMB, 3) the impact of multimodality imaging on EMB, and 5) the current clinical practice in the worldwide use of EMB. (HF).”
 
The HFA/HFSA/JHFS Position Statement on Endomyocardial Biopsy is a timely document as it has been over a decade since a comprehensive statement on endomyocardial biopsy was published. Clearly, as imaging and molecular/genetic techniques have evolved the indications for heart biopsy have changed. This international perspective acknowledges both differences and similarities in the use of endomyocardial biopsy globally and will widen everyone’s appreciation for the use of this important, diagnostic tool.  
 
The HFA/HFSA/JHFS Position Statement on Endomyocardial Biopsy has been jointly published by the Journal of Cardiac Failure, the official journal of the HFSA and the JHFS, and the European Journal of Heart Failure, the official journal of the HFA-ESC. 

Trilateral International Heart Failure Consensus Conference (TIHF)

The three professional societies gather annually at the Trilateral International Heart Failure Consensus Conference (TIHF) to address and develop a joint publication on significant topics of interest in the heart failure. In 2020, HFSA led the TIHF on the topic of the universal definition and classification of heart failure, while HFSA-ESC has led the way on the topic of endomyocardial biopsy. 

Resource Links

The HFA/HFSA/JHFS Position Statement on Endomyocardial Biopsy can be accessed via the link below:  

  • DOI: https://doi.org/10.1016/j.cardfail.2021.04.010 

About the Heart Failure Society of America 

The Heart Failure Society of America, Inc. (HFSA) represents the first organized effort by heart failure experts from the Americas to provide a forum for all those interested in heart function, heart failure, and congestive heart failure (CHF) research and patient care. The mission of HFSA is to provide a platform to improve and expand heart failure care through collaboration, education, innovation, research, and advocacy. HFSA members include physicians, scientists, nurses, nurse practitioners, pharmacists, trainees, other healthcare workers and patients. For more information, visit hfsa.org

About the Heart Failure Association of the European Society of Cardiology 

As the world's largest heart failure association, the Heart Failure Association of the ESC prioritises patient management and awareness of heart failure as a global health problem. HFA-ESC's mission is to improve quality of life and longevity through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research. Learn more online

 
About the Japanese Heart Failure Society 

In response to the increased interest in heart failure, based on the basic studies on its mechanisms and clinical trials, the Japanese Heart Failure Society (JHFS) was established in 1996. The first General and Scientific Meeting of the JHFS was held in October 1997 at the Kyoto International Conference Center. The number of members increased from 900 to approximately 4000 in 2020. The vision of JHFS is to enrich the happy life of the patients and their families through investigating the basic pathophysiology of heart failure, and developing the effective and efficient diagnosis, prevention and treatment strategies. 

About the Journal of Cardiac Failure 

Launched in 1994 and a joint endeavor by the Heart Failure Society of America and the Japanese Heart Failure Society, the Journal of Cardiac Failure publishes peer-reviewed manuscripts of interest to clinicians and researchers in the field of heart failure and related disciplines. These include original communications of scientific importance and review articles involving clinical research, health services and outcomes research, animal studies, and bench research with potential clinical applications to heart failure. The Journal also publishes manuscripts that report the design of ongoing clinical trials and editorial perspectives that comment on new developments pertinent to the field of heart failure or manuscripts published in other journals. Visit the JCF online

About the European Journal of Heart Failure 

The European Journal of Heart Failure (EJHF) is dedicated to the advancement of knowledge in the field of heart failure management. The journal publishes reviews and editorials to improve the understanding, prevention, investigation and treatment of heart failure. Molecular and cellular biology, pathology, physiology, electrophysiology, pharmacology, as well as clinical, social and population sciences all form part of the discipline. Visit EJHF online.


Media Contact:  

Laura Poko: Director of Marketing and Communications, Heart Failure Society of America, 301-798-4493, ext. 226 lpoko@hfsa.org 

Jacqueline Partarrieu, Media Team Manager, Communication and Marketing Division, European Society of Cardiology, +33 (0)4 8987 2499, jpartarrieu@escardio.org